CompletedPhase 2

Effectiveness of Cognitive-Affective Behavior Therapy for the Treatment of Somatization Disorder

United States88 participantsStarted 2003-08

Plain-language summary

This study will examine the long-term effect of cognitive-affective behavior therapy on the physical symptoms, functioning, and health care utilization of people with somatization disorder.

Who can participate

Age range18 Years – 65 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Meets DSM-IV criteria for somatization disorder * Available for follow-up over the ensuing 18 months * English-speaking Exclusion Criteria: * Meets DSM-IV criteria for a psychotic disorder, organic brain syndrome, or psychoactive substance dependence (Other psychiatric comorbidity is not exclusionary) * Active suicidal ideation * Unstable major medical condition * Plans to engage in additional psychotherapy during the first 6 months after enrollment * Current use of any medication that has not been stabilized for the previous 2 months

What they're measuring

Clinical Global Impression Scale for Somatization Disorder

Timeframe: Measured at baseline and Months 4, 10, and 16

Trial details

NCT IDNCT00149760

SponsorRutgers, The State University of New Jersey

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2010-02

View on ClinicalTrials.gov More Somatization Disorder trials